1999, for review). Recent reports have shown that
150 ng/ml (data not shown). Figure 1B illustrates that a 10 min long exposure to insulin or IGF-1 produced an GluR2-containing AMPA receptors at the postsynaptic attenuation of AMPA current similar to that seen with plasma membrane of hippocampal neurons are rapidly continuous exposure (insulin: 62% Ϯ 8% of baseline at and selectively internalized in a manner that requires t ϭ 40 min, n ϭ 5; IGF-1: 54% Ϯ 9%, n ϭ 6). Neither this clathrin complex (Carroll et Cultures were pretreated with external application of a AMPA receptors that lacked the GluR2 subunit. These monoclonal antiserum directed against the IGF-1 recepexperiments were performed using immunocytochemitor (3 g/ml), which has been shown to block IGF-1 cal measurements in a heterologous expression system binding (Kull et al., 1983 ). This treatment, but not prein-(HEK293 cells) and cultured hippocampal neurons, as cubation with preimmune mouse immunoglobulin G well as measurements of EPSCs at Schaffer collateral-(IgG) as a control, completely blocked the effect of IGF-1 CA1 pyramidal cell synapses in hippocampal slices.
(anti-IGF-1-R: 105% Ϯ 7% of baseline at t ϭ 40 min, Thus, our first task was to attempt to replicate the basic n ϭ 6; control IgG: 53% Ϯ 10%, n ϭ 7). A similar blockade electrophysiological findings using the cerebellar Pur-(99% Ϯ 6%, n ϭ 5) was also seen using pretreatment kinje neuron in culture. While mature Purkinje neurons with a peptide (CYAAPLPAKSC, 1 g/ml) reported to do not express functional NMDA receptors, they are block IGF-1 receptor activation ( has been shown to block clathrin-mediated endocytosis to the external saline, and V hold was set to Ϫ50 mV. in rat brain synaptosomes (Marks and McMahon, 1998) Following acquisition of baseline responses, either insuresulted in a near complete blockade of the IGFlin (500 nM) or IGF-1 (50 ng/ml) was applied externally 1-induced attenuation of AMPA currents (90% Ϯ 7% of and was maintained for the duration of the recording baseline at t ϭ 40 min, n ϭ 6). Second, the internal saline ( Figure 1A ). These treatments induced an attenuation of was supplemented with a glutathione S-transferase fu-AMPA currents (insulin: 59% Ϯ 8% of baseline at t ϭ sion peptide derived from the SH3 domain of amphiphy-40 min, mean Ϯ SEM, n ϭ 6; IGF-1: 52% Ϯ 8% of sin, the region that binds the proline-rich domain of baseline, n ϭ 7) but not NMDA currents (insulin: 103% Ϯ dynamin I (Grabs et al., 1997). Introduction of this pep-7%; IGF-1: 105% Ϯ 7%), which reached a steady-state tide, but not a mutant control peptide, into the presynaplevel within ‫02ف‬ min and then persisted for the duration tic terminal of the lamprey giant reticulospinal synapse of the recording. Pilot experiments indicated that similar has previously been shown to result in a dramatic impairment of clathrin-mediated synaptic vesicle endocytosis results were produced with IGF-1 at a concentration of neurons (50 ng/ml, t ϭ 0-10 min) failed to produce either a transient (101% Ϯ 6% of baseline at t ϭ 10 min, n ϭ 100 g/ml) blocked the effect of IGF-1 (93% Ϯ 8% of baseline, n ϭ 7), but the scrambled control peptide 5) or a sustained (98% Ϯ 8% of baseline at t ϭ 40 min) alteration. This failure is likely to reflect the absence of (QPPASNPRVR, 100 g/ml) did not (57% Ϯ 8%, n ϭ 5). These three results indicate that postsynaptic clathrinGluR2 in these cells, but it also could result from the absence of a portion of the signaling mechanisms that mediated endocytosis is required for the rapid attenuation of AMPA currents that is produced by IGF-1 recepcouple IGF-1 receptor activation to the activation of clathrin-mediated endocytosis. tor activation. Further experiments using transient transfection with a dominant-negative dynamin construct (as While experiments that utilize exogenous AMPA test pulses are useful in that they allow for the analysis of performed in Man et al., 2000) could not be completed, (A) Attenuation of AMPA receptor-mediated currents by brief application IGF-1 (50 ng/ ml, t ϭ 0-10 min, heavy horizontal bar) was blocked by external application of an inhibitory IGF-1 analog peptide (1 g/ml, n ϭ 5) or an antibody directed against the external portion of the IGF-1 receptor (3 g/ml, n ϭ 6) but not control mouse IgG (3 g/ml, n ϭ 7). These compounds were applied from t ϭ Ϫ15 to 15 min, as indicated by the light horizontal bar. Inclusion in the patch-pipette saline of an antibody directed against the insulin receptor kinase domain (which is highly conserved in the IGF-1 receptor) was also effective in blocking the effect of IGF-1 (20 g/ml, n ϭ 5). (B) IGF-1-evoked attenuation of AMPA currents was also blocked by manipulations that interfere with clathrin-mediated endocytosis, such as inclusion in the patch-pipette saline of BAPTA (20 mM, n ϭ 6), a peptide based on the sequence of the amphiphysin SH3 domain (AmphSH3, 100 g/ml, n ϭ 5), or a peptide based on the amphiphysin binding motif from the proline-rich domain of dynamin I (dynaminPRD, 100 g/ml, n ϭ 7). A mutant form of the amphiphysin SH3 peptide that does not bind dynamin I (AmphSH3mut, 100 g/ ml, n ϭ 5) and a scrambled dynamin control peptide (dynCONTROL, 100 g/ml, n ϭ 5) failed to block the effect of IGF-1. Representative current traces were acquired at the times indicated on the graph. (C) Measures of AMPA mEPSC amplitude and frequency were made from a population of Purkinje neurons treated with IGF-1 (50 ng/ml, n ϭ 7) and from a subset of these cells, which were subsequently exposed to the AMPA receptor desensitization blocker cyclothiazide (100 M, n ϭ 5). Separate groups of Purkinje neurons were pretreated for Ն12.5 min with the following drugs prior to IGF-1 application: anti-IGF-1-R (3 g/ml, external, n ϭ 6), control IgG (3 g/ml, external, n ϭ 5), dynaminPRD (100 g/ml, internal, n ϭ 8), and dynCONTROL (100 g/ml, n ϭ 5). /ml, t ϭ 15-25 min) , and test pulses were continued (n ϭ 7). In a control group, the quisqualate/depolarization conjunction was omitted (n ϭ 6). (B) Representative current traces taken at the times indicated in (A) Scale bars, 30 pA, 1 s. (C) Occlusion experiment the reverse of the one illustrated in (A) utilized perforated-patch recording. AMPA currents were attenuated by IGF (50 ng/ml at t ϭ 0-10 min). Subsequently, quisqualate/depolarization conjunction was applied (t ϭ 32.5 min), and test pulses were continued (n ϭ 5). In a control group, the IGF-1 application was omitted (n ϭ 5).
6-cyano-7-dinitroquinoxaline-2,3-dione (Linden et al., group of Purkinje cells received quisqualate test pulses from t ϭ Ϫ10 to 15 min without quisqualate/depolariza-1993). Following acquisition of baseline responses to quisqualate test pulses, six conjunctive stimuli, each tion conjunctive stimulation. When IGF-1 was then applied at t ϭ 15-25 min, quisqualate-evoked currents consisting of a quisqualate pulse together with a 3 s long depolarizing step to 0 mV, were applied at t ϭ 0 were strongly attenuated (53% Ϯ 9% at t ϭ 35 min, n ϭ 6). This argues that the failure of IGF-1 to induce further min. This resulted in a rapid depression of subsequent test pulses (54% Ϯ 8% of baseline at t ϭ 10 min, n ϭ attenuation in the former case results from occlusion by prior LTD induction rather than a nonspecific effect 7), as has been previously described (Linden et al., 1991 (Linden et al., , 1993 . When IGF-1 was then applied at t ϭ 15-25 min, related to the duration of the whole-cell recording. To further address this point, a reverse occlusion experifurther attenuation of quisqualate-evoked currents was minimal (45% Ϯ 10% at t ϭ 35 min). As a control, another ment was also performed in which prior exposure to These included a peptide based on the sequence of the amphiphysin SH3 domain (AmphSH3, 100 g/ml, n ϭ 5) or a peptide based on the amphiphysin binding motif from the proline-rich domain of dynamin I (dynaminPRD, 100 g/ml, n ϭ 7). A mutant form of the amphiphysin SH3 peptide that does not bind dynamin I (AmphSH3mut, 100 g/ml, n ϭ 5) or a scrambled dynamin control peptide (dynCONTROL, 100 g/ml, n ϭ 5) had no significant effect on LTD. Representative current traces were acquired at the times indicated on the graph. Scale bars, 30 pA, 1 s.
IGF-1 occluded subsequent induction of LTD by quis-
of an inhibitory IGF-1 analog peptide (1 g/ml), applicaqualate/depolarization conjunction ( Figure 5C ). This extion of an antibody directed against the external portion periment required perforated-patch as opposed to of the IGF-1 receptor (3 g/ml), and internal application whole-cell recording, as whole-cell recording for Ͼ30 of an antibody directed against the insulin receptor kimin begins to nonspecifically reduce the amplitude of nase domain (20 g/ml), were previously shown to block cerebellar LTD induction (the so-called "washout efthe attenuation of AMPA currents produced by exogefect," which is also seen in hippocampal LTP).
nous IGF-1 (Figure 2A ). However, robust and persistent The experimental evidence to this point suggests LTD was evoked using all of these treatments (anti-IGFthree possible models to explain the interaction of insu-1-R: 54% Ϯ 9% of baseline at t ϭ 42.5 min, n ϭ 6; antilin/IGF-1 effects and LTD expression. First, quisqualate/ insulin-R kinase domain: 53% Ϯ 9%, n ϭ 7; IGF-1 analog depolarization conjunction results in the activation of peptide: 52% Ϯ 8%, n ϭ 6), indicating that LTD induction IGF-1/insulin receptors to trigger clathrin-mediated indoes not require activation of insulin/IGF-1 receptors, ternalization of AMPA receptors and thereby express thereby eliminating the first model described above.
LTD. Second, quisqualate/depolarization conjunction
To distinguish between the remaining two models, results in neither insulin/IGF-1 receptor activation nor inhibitors of the clathrin endocytotic complex were apclathrin-mediated internalization, and LTD is expressed plied prior to LTD induction ( Figure 6B ). Two peptides through a different set of mechanisms. Third, quisquadesigned to block the amphiphysin/dynamin I interlate/depolarization conjunction does not activate insulin/ action, one based on the dynamin I proline-rich do-IGF-1 receptors, but, through a converging intermediary main and another based on the amphiphysin SH3 step, does activate clathrin-mediated internalization of domain, both produced a near complete blockade of AMPA receptors to express LTD. To begin to distinguish LTD induced by quisqualate/depolarization conjunction among these models, LTD was induced by quisqualate/ (AmphSH3: 87% Ϯ 7% of baseline at t ϭ 42.5 min, n ϭ depolarization conjunction in the presence of com-5; dynaminPRD: 92% Ϯ 9%, n ϭ 7). Control peptides pounds designed to block IGF-1/insulin receptor signaling ( Figure 6A ). All three treatments, external application that do not block the dynamin I/amphiphysin interaction 
